A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1568-5608
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease ; volume:30 ; number:3 ; day:24 ; month:4 ; year:2022 ; pages:705-712 ; date:6.2022
Inflammopharmacology ; 30, Heft 3 (24.4.2022), 705-712, 6.2022
- Creator
-
Tardella, Marika
Di Carlo, Marco
Carotti, Marina
Ceccarelli, Luca
Giovagnoni, Andrea
Salaffi, Fausto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10787-022-00936-w
- URN
-
urn:nbn:de:101:1-2022072820515918508645
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tardella, Marika
- Di Carlo, Marco
- Carotti, Marina
- Ceccarelli, Luca
- Giovagnoni, Andrea
- Salaffi, Fausto
- SpringerLink (Online service)
Other Objects (12)
Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
Pleuroparenchymal fibroelastosis in rheumatoid arthritis-associated interstitial lung disease
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data
Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease
Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
Pleuroparenchymal fibroelastosis in rheumatoid arthritis-associated interstitial lung disease
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data
Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease
Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
Pleuroparenchymal fibroelastosis in rheumatoid arthritis-associated interstitial lung disease
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data